Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell
Stopped early · Phase 1 · Has a placebo group
Conditions studied: Food Intake
In brief
The purpose of this study is to determine whether the blood pressure medication, diltiazem, will temporarily decrease the sense of smell when given in a nasal spray which will then reduce food intake.
Key facts
- Study ID
- NCT01021176
- Run by
- Pennington Biomedical Research Center
- People needed
- 12
- Starts
- 2009-10-01
- Expected to finish
- 2009-11-01
- Last updated by the study team
- 2015-12-18
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Body mass index (BMI) between 25 and 40 kg
- Blood pressure in within normal range
You may not qualify if…
- Used tobacco products in the past month
- Used a calcium channel blocker medication in the last month
- used nasal sprays in the last month
- have an abnormal sense of smell or abnormalities of the lining in your nose
- female and have irregular menstrual periods
- female and are nursing a baby or pregnant
- female and have had a partial hysterectomy (still have ovaries)
Where it is running
- Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.